Gabriela Dieguez, MSc
Articles
March 16th 2023
Heidi S. Wirtz, PharmD, PhD Zsolt Hepp, PharmD, MSc Simrun Grewal, PhD Phoebe Wright, PharmD, MSc Rupali Fuldeore, MSc Samantha Tomicki, MPH Jared Hirsch, MSc Gabriela Dieguez, MSc L. Johnetta Blakely, MD
Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 13th 2024 | Updated: September 20th 2024
T-DXd Sustained Substantial, Durable Clinical Activity in Patients With HER2+ Metastatic Breast Cancer
Published: September 16th 2024 | Updated: September 20th 2024
Multifaceted Approach Can Help Patients Benefit From the Expanded Lipid-Lowering Toolbox
Published: September 4th 2024 | Updated: September 20th 2024
RSV Vaccine Shows High Effectiveness Against Hospitalization in Older Adults
Published: September 17th 2024 | Updated: September 20th 2024
Frameworks for Advancing Health Equity: Youth Behavioral Health Strategy Program
Published: September 5th 2024 | Updated: September 20th 2024
Combatting the Opioid Epidemic With Dr Michael Lynch
